Skip to main content
Autobound logo
Medline10-K: Restructuring

Recent Dec 2025 IPO creates new public company costs and Sarbanes-Oxley compliance needs.

Read at SEC EDGAR

What happened

Following its December 2025 IPO, Medline is facing new, significant costs and compliance burdens related to operating as a public company, including Sarbanes-Oxley.

Source

SEC EDGARFeb 25, 2026

Annual report (Form 10-K)

Medline 10-K for FY2025

Filing excerpt

On December 18, 2025, we completed our IPO of 248,439,654 shares of Class A common stock...

sec.gov/Archives/edgar/data/2046386/000204638626000009/mdln-20251231.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 25, 2026

More from Medline

Company page →

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
2046386
Accession number
0002046386-26-000009
Timeframe
Current year
Filing year
2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Mar 3, 2026
signal_type
sec-10k
signal_subtype
restructuring

Use this data

Get every 10-K signal for Medline and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medline this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/f56bf11f-3d40-441f-92e2-b1b2c46fd7ac returns this record as JSON. POST /v1/companies/enrich returns every signal for medline.com.

{
  "signal_id": "f56bf11f-3d40-441f-92e2-b1b2c46fd7ac",
  "signal_type": "sec-10k",
  "signal_subtype": "restructuring",
  "detected_at": "2026-03-03T05:49:05.617+00:00",
  "company": {
    "name": "Medline",
    "domain": "medline.com"
  },
  "data": {
    "detail": "Following its December 2025 IPO, Medline is facing new, significant costs and compliance burdens related to operating as a public company, including Sarbanes-Oxley. This triggers immediate needs for legal, accounting, consulting, and GRC (Governance, Risk, and Compliance) software and services.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Recent Dec 2025 IPO creates new public company costs and Sarbanes-Oxley compliance needs.",
    "excerpts": "On December 18, 2025, we completed our IPO of 248,439,654 shares of Class A common stock...",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/mdln-20251231.htm",
    "filing_date": "2026-02-25",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.